Erin N. Kane's Insider Trades & SAST Disclosures
Erin N. Kane's most recent trade in Chemours Company was a trade of 14,096 Common Stock done . Disclosure was reported to the exchange on April 22, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Erin N. Kane.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Chemours Company | Erin N. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2025 | 14,096 | 65,194 (0%) | 0% | 0 | Common Stock | |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 64,865 | 545,447 (1%) | 0% | 0 | Common Stock, par value $0.01 | |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.75 per share. | 28 Feb 2025 | 22,213 | 480,582 (1%) | 0% | 27.8 | 616,411 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 30.12 per share. | 03 Feb 2025 | 4,400 | 503,395 (1%) | 0% | 30.1 | 132,528 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 30.71 per share. | 03 Feb 2025 | 600 | 502,795 (1%) | 0% | 30.7 | 18,426 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.10 per share. | 02 Jan 2025 | 4,700 | 508,095 (1%) | 0% | 28.1 | 132,070 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.90 per share. | 02 Jan 2025 | 300 | 507,795 (1%) | 0% | 28.9 | 8,670 | Common Stock, par value $0.01 |
| AdvanSix Inc | Kane N. Erin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 32.29 per share. | 02 Dec 2024 | 5,000 | 512,795 (1%) | 0% | 32.3 | 161,450 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 30.15 per share. | 01 Nov 2024 | 3,500 | 519,295 (1%) | 0% | 30.2 | 105,525 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 30.87 per share. | 01 Nov 2024 | 1,500 | 517,795 (1%) | 0% | 30.9 | 46,305 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 30.28 per share. | 01 Oct 2024 | 5,000 | 522,795 (1%) | 0% | 30.3 | 151,400 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.25 per share. | 03 Sep 2024 | 4,900 | 527,895 (1%) | 0% | 28.3 | 138,425 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.11 per share. | 03 Sep 2024 | 100 | 527,795 (1%) | 0% | 29.1 | 2,911 | Common Stock, par value $0.01 |
| Chemours Company | Erin N. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2024 | 8,547 | 48,884 (0%) | 0% | 0 | Common Stock | |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.87 per share. | 02 Aug 2024 | 3,442 | 532,795 (1%) | 0% | 27.9 | 95,929 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.89 per share. | 01 Aug 2024 | 1,558 | 536,237 (1%) | 0% | 27.9 | 43,453 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.86 per share. | 30 Jul 2024 | 8,079 | 537,795 (1%) | 0% | 27.9 | 225,081 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.92 per share. | 30 Jul 2024 | 6,921 | 545,834 (1%) | 0% | 27.9 | 193,234 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.08 per share. | 02 Apr 2024 | 3,002 | 552,755 (1%) | 0% | 28.1 | 84,296 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.86 per share. | 02 Apr 2024 | 613 | 555,757 (1%) | 0% | 27.9 | 17,078 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.30 per share. | 28 Mar 2024 | 5,000 | 557,755 (1%) | 0% | 28.3 | 141,500 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.96 per share. | 28 Mar 2024 | 1,385 | 556,370 (1%) | 0% | 28.0 | 38,725 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 106,213 | 553,121 (1%) | 0% | 0 | Common Stock, par value $0.01 | |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 63,962 | 562,755 (2%) | 0% | 0 | Common Stock, par value $0.01 | |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.36 per share. | 28 Feb 2024 | 54,328 | 498,793 (1%) | 0% | 27.4 | 1,486,414 | Common Stock, par value $0.01 |
| AdvanSix Inc | Kane Erin N. | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.81 per share. | 24 Feb 2024 | 13,596 | 446,908 (1%) | 0% | 27.8 | 378,105 | Common Stock, par value $0.01 |
| Chemours Company | Kane N. Erin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 792 | 10,261 | - | - | Stock Units | |
| Chemours Company | Erin N. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 891 | 9,392 | - | - | Stock Units | |
| Chemours Company | Erin N. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 677 | 8,434 | - | - | Stock Units | |
| Chemours Company | Erin N. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2023 | 5,858 | 38,654 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Erin N. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 835 | 7,700 | - | - | Stock Units | |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 44,345 | 44,345 | - | - | Stock Option (right to buy) | |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 43,478 | 43,478 | - | - | Stock Option (right to buy) | |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 19,417 | 460,504 (1%) | 0% | 0 | Common Stock, par value $0.01 | |
| Chemours Company | Erin N. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 816 | 6,806 | - | - | Stock Units | |
| Chemours Company | Erin N. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 1,014 | 5,940 | - | - | Stock Units | |
| Chemours Company | Erin N. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 780 | 4,890 | - | - | Stock Units | |
| Chemours Company | Erin N. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 4,442 | 31,785 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Erin N. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 794 | 4,080 | - | - | Stock Units | |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 57,102 | 57,102 | - | - | Stock Option (right to buy) | |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 37,721 | 380,911 (1%) | 0% | 0 | Common Stock, par value $0.01 | |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.15 per share. | 28 Feb 2022 | 29,415 | 351,496 (1%) | 0% | 39.1 | 1,151,597 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 20,434 | 371,980 (1%) | 0% | 0 | Common Stock, par value $0.01 | |
| Chemours Company | Erin N. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2021 | 744 | 3,257 | - | - | Stock Units | |
| Chemours Company | Erin N. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 860 | 2,493 | - | - | Stock Units | |
| Chemours Company | Erin N. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 718 | 1,620 | - | - | Stock Units | |
| Chemours Company | Erin N. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2021 | 4,653 | 26,501 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Erin N. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 895 | 895 | - | - | Stock Units | |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.81 per share. | 02 Mar 2021 | 7,038 | 343,190 (1%) | 0% | 28.8 | 202,765 | Common Stock, par value $0.01 |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 72,532 | 72,532 | - | - | Stock Option (right to buy) | |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 25,677 | 350,228 (1%) | 0% | 0 | Common Stock, par value $0.01 |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges